Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

  1. Pfeifer, H.
  2. Cazzaniga, G.
  3. van der Velden, V.H.J.
  4. Cayuela, J.M.
  5. Schäfer, B.
  6. Spinelli, O.
  7. Akiki, S.
  8. Avigad, S.
  9. Bendit, I.
  10. Borg, K.
  11. Cavé, H.
  12. Elia, L.
  13. Reshmi, S.C.
  14. Gerrard, G.
  15. Hayette, S.
  16. Hermanson, M.
  17. Juh, A.
  18. Jurcek, T.
  19. Chillón, M.C.
  20. Homburg, C.
  21. Martinelli, G.
  22. Kairisto, V.
  23. Lange, T.
  24. Lion, T.
  25. Mueller, M.C.
  26. Pane, F.
  27. Rai, L.
  28. Damm-Welk, C.
  29. Sacha, T.
  30. Schnittger, S.
  31. Touloumenidou, T.
  32. Valerhaugen, H.
  33. Vandenberghe, P.
  34. Zuna, J.
  35. Serve, H.
  36. Herrmann, E.
  37. Markovic, S.
  38. van Dongen, J.J.M.
  39. Ottmann, O.G.
  40. Show all authors +
Journal:
Leukemia

ISSN: 1476-5551,  0887-6924

Year of publication: 2020

Volume: 34

Issue: 7

Pages: 1970

Type: Erratum

DOI: 10.1038/S41375-020-0707-2 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus